Point72 Asset Management, L.P. - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$10,564,378
+1582.2%
1,757,800
+1529.0%
0.04%
+1100.0%
Q3 2022$628,000
-84.5%
107,910
-84.1%
0.00%
-82.4%
Q2 2022$4,059,000–679,843–0.02%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders